Question 1

What is the Meaning of Container Closure Integrity?

Accepted Answer

Container Closure Integrity (CCI) is the critical attribute of a pharmaceutical packaging system that maintains a sterile, hermetic seal throughout a drug product's entire shelf life. This integrity ensures that the primary container and its closure mechanism prevent the ingress of external contaminants, including microorganisms, gases like oxygen, or moisture. For injectable hormone therapies, which must remain sterile, a verified CCI system is an absolute requirement for patient safety and therapeutic efficacy. Failure of CCI directly compromises the drug's quality, strength, and purity.

Question 2

What is the Origin of Container Closure Integrity?

Accepted Answer

The concept of Container Closure Integrity originates from stringent pharmaceutical regulatory requirements, notably those mandated by the FDA in their Current Good Manufacturing Practice (cGMP) regulations, such as 21 CFR Part 211. This focus evolved from earlier, less reliable sterility testing methods to a proactive, engineering-based approach to packaging quality control. The modern standard, guided by compendial chapters like USP , mandates deterministic, quantitative testing methods to prove the package seal is a microbial barrier. This scientific rigor is essential for all sterile medications, including compounded bioidentical hormones.

Question 3

What is the Mechanism of Container Closure Integrity?

Accepted Answer

The mechanism operates by maintaining a maximum allowable leak limit (MALL) for the container-closure system, essentially ensuring the physical seal remains smaller than the size of a bacterium or reactive gas molecule. Testing methods, such as vacuum decay, helium leak detection, or dye ingress, are used to quantitatively measure the package's ability to exclude contaminants. This functional barrier mechanism prevents the degradation of sensitive hormone molecules by oxidation or hydrolysis and ensures the dose remains potent until the patient utilizes the medication. A robust CCI system is the physical safeguard of the drug's chemical and microbiological stability.

Container Closure Integrity

Meaning

Origin

Mechanism

What Are the Specific FDA Requirements for Outsourcing Facilities?

Provided by the clinical team
at 4Ever Young Miami Dadeland

-15% ∞ HRTIO15

Your protocol begins with a conversation.

Visit

Schedule Appointment

About

Med & Wellness

4Ever Young Miami Dadeland

Communication

+1 786-529-6686

Email Us

Opening Hours